Reply to Francesco Piva, Matteo Santoni, Marina Scarpelli, et al's Letter to the Editor re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4

Journal article

Open access

Peer reviewed

Tim N. Beck, Erica A. Golemis and Daniel M. Geynisman

European urology, v 70(3), pp E75-E76

01 Sep 2016

PMID: 26947605

Files and links (1)

url

https://europepmc.org/articles/pmc4975993View

Life Sciences & Biomedicine

Science & Technology

Urology & Nephrology

12 Record Views

Title: Reply to Francesco Piva, Matteo Santoni, Marina Scarpelli, et al's Letter to the Editor re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4
Creators: Tim N. Beck - Fox Chase Cancer Center
Erica A. Golemis - Fox Chase Cancer Center
Daniel M. Geynisman - Fox Chase Cancer Center
Publication Details: European urology, v 70(3), pp E75-E76
Publisher: Elsevier
Number of pages: 2
Grant note: R21CA181287 / NATIONAL CANCER INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) R21 CA181287; P30 CA006927; F30 CA180607 / NCI NIH HHS; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)
Resource Type: Journal article
Language: English
Academic Unit: Biochemistry and Molecular Biology
Web of Science ID: WOS:000380754000004
Scopus ID: 2-s2.0-84959289272
Other Identifier: 991019318932104721

This publication has contributed to the advancement of the following goals:

Data related to this publication, from InCites Benchmarking & Analytics tool: